Max Healthcare Institute (543220) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
2 Feb, 2026Executive summary
Operationalized a new 303-bed hospital in Dwarka, South Delhi, with advanced technology and strong initial traction; launched under O&M contract with financial assistance approved.
Announced a build-to-suit 250+ bed hospital in Zirakpur (Mohali), Punjab, on a long-term lease, targeting regional expansion and to be developed by FY28.
Successfully ramped up recently acquired Lucknow and Nagpur hospitals, contributing INR 99 crore to revenue and INR 18 crore to operating EBITDA in Q1, with ARPOB at INR 45,300.
Completed most post-merger integration activities, expecting further improvements as new clinical teams join and infrastructure upgrades.
Appointment of Mr. Gautam Wadhwa as Director & Chief Business Officer effective August 5, 2024.
Financial highlights
Network gross revenue reached INR 2,028 crore, up 18% year-on-year and 7% quarter-on-quarter; net revenue was INR 1,935 crore, up 19% year-on-year.
Network operating EBITDA was INR 499 crore (net of INR 6 crore one-time pre-launch cost at Dwarka), up 14% year-on-year; margin at 25.8%.
Profit after tax was INR 295 crore, compared to INR 291 crore in Q1 last year and INR 311 crore in the previous quarter.
Free cash flow from operations was INR 258 crore, with INR 213 crore deployed towards capacity expansion and upgrades.
Net cash position stood at INR 66 crore at June 2024 end.
Outlook and guidance
Substantial improvements expected during the year, especially as integration and upgrades at new hospitals progress.
Oncology and surgical mix expansion in new units expected to drive ARPOB and profitability higher in coming quarters.
Dwarka hospital expected to break even within 6-8 months of launch.
Brownfield expansion plans to double bed capacity in 4-5 years; strong free cash flows and low leverage support future M&A and greenfield projects.
Expansion plans include a new 250+ bed hospital in Zirakpur, Punjab, to be operational within 48 months, targeting high-growth regions.
Latest events from Max Healthcare Institute
- Q3 FY26 delivered strong growth, with expansion and regulatory changes shaping future performance.543220
Q3 25/266 Feb 2026 - Strong revenue and EBITDA growth, major acquisitions, and expansion marked the quarter.543220
Q2 24/2516 Jan 2026 - Q3 FY25 revenue up 34% YoY, EBITDA up 32%, with major expansion and strong cash flow.543220
Q3 24/259 Jan 2026 - Revenue up 27% YoY, EBITDA up 23%, and PAT up 17% amid robust expansion and digital growth.543220
Q1 25/2623 Nov 2025 - FY25 revenue up 26% with strong EBITDA growth, expansion, and a recommended dividend.543220
Q4 24/2518 Nov 2025 - Q2 FY26 saw strong growth, expansion, and digital gains, supported by key divestments and a merger.543220
Q2 25/2617 Nov 2025